Clinical Trial Update: A Study of Dosing Patterns and Costs in Patients With Spinal Muscular Atrophy Receiving Disease Modifying Therapies

View source ↗

Summary

A completed clinical trial examining dosing patterns and costs in spinal muscular atrophy patients receiving disease-modifying therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Muscular Atrophy, Spinal | Status: COMPLETED